Skip to main content
SpringerLink
Log in

Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

The marked clinical heterogeneity of CLL makes early prognosis assessment important. Lipoprotein lipase (LPL) has been shown to confer adverse prognosis in CLL, recent data indicating it might also contribute to CLL cell survival and metabolism. We determined LPL mRNA expression in unselected peripheral blood of 84 CLL patients by RT PCR. Results were correlated with other prognostic markers and outcome. 30/84 (40 %) of cases were LPL positive based on the cutoff established by ROC analysis. In LPL positive patients significantly shorter median survival (136 vs 258 months, p < 0.0001) and time to first treatment intervals (36 vs 144 months, p < 0.002) were documented. LPL values correlated with male gender, higher stages, more treatment requirement, CD38 positivity and unmutated IgVH genes. Among cases with 13q deletion, LPL positivity identified a subcohort with poor outcome (median survival 108 months vs NR, p < 0.0001). In multivariate analysis, cytogenetic aberrations and LPL had significant impact on survival. Our results confirm that LPL is a strong predictor of outcome in CLL, able to improve prognostic accuracy in good risk cytogenetic subgroups. The relationship between its prognostic and functional role in CLL needs to be explored further.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK (1999) Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94(6):1848–1854

    CAS  PubMed  Google Scholar 

  2. Damle RN, Wasil T, Fais F et al (1999) IgV Gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94:1840–1847

    CAS  PubMed  Google Scholar 

  3. Chiorazzi N (2012) Implications of new prognostic markers in chronic lymphocytic leukemia. Hematology 2012:76–87

    PubMed  Google Scholar 

  4. Kröber A, Seiler T, Benner A, Bullinger L, Brückle E, Lichter P, Döhner H, Stilgenbauer S (2002) VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100:1410–1416

    PubMed  Google Scholar 

  5. Rosenwald A, Alizadeh AA, Widhopf G et al (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194(11):1639–1647

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Klein U, Tu Y, Stolovitzky GA, Mattioli M, Cattoretti G, Husson H, Freedman A, Inghirami G, Cro L, Baldini L, Neri A, Califano A, Dalla-Favera R (2001) Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 194(11):1625–1638

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Oppezzo P, Vasconcelos Y, Settegrana C et al (2005) The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood 106(2):650–657

    Article  CAS  PubMed  Google Scholar 

  8. Heintel D, Kienle D, Shehata M et al (2005) High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia 19(7):1216–1223

    Article  CAS  PubMed  Google Scholar 

  9. Nückel H, Hüttmann A, Klein-Hitpass L, Schroers R, Führer A, Sellmann L, Dührsen U, Dürig J (2006) Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 47(6):1053–1061

    Article  PubMed  Google Scholar 

  10. van’t Veer MB, Brooijmans AM, Langerak AW et al (2006) The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. Haematologica 91(1):56–63

    PubMed  Google Scholar 

  11. Van Bockstaele F, Pede V, Janssens A, Callewaert F, Offner F, Verhasselt B, Philippé J (2007) Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia. Clin Chem 53(2):204–212

    Article  CAS  PubMed  Google Scholar 

  12. Nikitin EA, Malakho SG, Biderman BV et al (2007) Expression level of lipoprotein lipase and dystrophin genes predict survival in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 48(5):912–922

    Article  CAS  PubMed  Google Scholar 

  13. Xu W, Li JY, Shen QD, Wu YJ, Yu H, Fan L (2009) Expression level of lipoprotein lipase in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors. Int J Lab Hematol 31(5):552–559

    Article  CAS  PubMed  Google Scholar 

  14. Kaderi MA, Kanduri M, Buhl AM et al (2011) LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia. Haematologica 96(8):1153–1160

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kristensen L, Kristensen T, Abildgaard N et al (2015) LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations. Eur J Haematol . doi:10.1111/ejh.1270017 Dec

    Google Scholar 

  16. Mead JR, Irvine SA, Ramji DP (2002) Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med 80(12):753–769

    Article  CAS  PubMed  Google Scholar 

  17. Kuemmerle NB, Rysman E, Lombardo PS et al (2011) Lipoprotein lipase links dietary fat to solid tumor cell proliferation. Mol Cancer Ther 10(3):427–436

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Dashnamoorthy R, Abermil N, Behesti A et al (2014) The lipid addiction of diffuse large B-cell lymphoma and potential treatment strategies with novel fatty acid synthase (FASN) small molecule inhibitors. Blood 124:4490

    Google Scholar 

  19. Zaidi N, Lupien L, Kuemmerle NB, Kinlaw WB, Swinnen JV, Smans K (2013) Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids. Prog Lipid Res 52(4):585–589

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Rozovski U, Grgurevic S, Bueso-Ramos C et al (2015) Aberrant LPL expression, driven by STAT3, mediates free fatty acid metabolism in CLL cells. Mol Cancer Res 13:944–953

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Rozovski U, Hazan-Halevy I, Barzilai M, Keating MJ, Estrov Z (2015) Metabolism pathways in chronic lymphocytic leukemia. Leuk Lymphoma 8:1–8

    Google Scholar 

  22. van Dongen JJ, Langerak AW, Brüggemann M, Evans PA, Hummel M, Lavender FL et al (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia 17(12):2257–2317

    Article  PubMed  Google Scholar 

  23. Matthews C, Catherwood M, Morris TC, Alexander HD (2004) Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocols. Leuk Lymphoma 45(9):1899–1904

    Article  PubMed  Google Scholar 

  24. Metz CE (1978) Basic principles of ROC analysis. Semin Nucl Med 8:283–298

    Article  CAS  PubMed  Google Scholar 

  25. Matrai Z, Sherrington PD, Pettitt AR, Zuzel M, Cawley JC (2003) CD38 expression in CLL is a marker of cell cycling activity. Blood 102(11):671a

    Google Scholar 

  26. Damle RN, Temburni S, Calissano C, Yancopoulos S, Banapour T, Sison C, Allen SL, Rai KR (2007) Chiorazzi N. CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. Blood 110:3352–3359

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Zubiaur M, Fernández O, Ferrero E, Salmerón J, Malissen B, Malavasi F, Sancho J (2002) CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt/protein kinase B and Erk activation in the absence of the CD3- immune receptor tyrosine-based activation motifs. J Biol Chem 277:13–22

    Article  CAS  PubMed  Google Scholar 

  28. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al (2003) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343:1910–1916

    Article  Google Scholar 

  29. Strefford JC, Parker H, Parker A, Robinson H, Chaplin T, Chen X et al (2009) 13q deletion size predicts disease progression and response to treatment in patients with chronic lymphocytic leukaemia. Blood 114:671

    Google Scholar 

  30. Pettitt AR, Emmens CJ, Lin K, Harris RJ (2005) Chronic lymphocytic leukaemia patients with a biallelic deletion of 13q14 have a more favourable profile of prognostic factors compared with cases that have a monoallelic 13q14 deletion. Blood 106:5019

    Google Scholar 

  31. Hernández JA, Rodríguez AE, González M et al (2009) A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia. Haematologica 94:364–371

    Article  PubMed  PubMed Central  Google Scholar 

  32. Ambrosio MR, Piccaluga PP, Ponzoni M, Rocca BJ, Malagnino V, Onorati M et al (2012) The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilin. PLoS One 7(8):e44315. doi:10.1371/journal.pone.0044315

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Porpaczy E, Tauber S, Bilban M et al (2013) Lipoprotein lipase in chronic lymphocytic leukaemia - strong biomarker with lack of functional significance. Leuk Res 37(6):631–636

    Article  CAS  PubMed  Google Scholar 

  34. Mansouri M, Sevov M, Fahlgren E, Tobin G, Jondal M, Osorio L, Roos G, Olivecrona G, Rosenquist R (2010) Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity. Leuk Res 34(3):301–306

    Article  CAS  PubMed  Google Scholar 

  35. Pallasch CP, Schwamb J, Konigs S, Schulz A, Debey S, Kofler D et al (2008) Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia 22:585–592

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haematology and Stem Cell Transplantation, St. István and St László Hospital, Budapest, Hungary

    Zoltán Mátrai, András Kozma, Emma Ádám, Gabriella Halm, Éva Karászi & Tamás Masszi

  2. Laboratory of Molecular Diagnostics, Hungarian National Blood Transfusion Service, Budapest, Hungary

    Hajnalka Andrikovics, Anikó Szilvási, András Bors & Attila Tordai

  3. Third Department of Internal Medicine, Semmelweis University, Budapest, Hungary

    Tamás Masszi

Authors
  1. Zoltán Mátrai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hajnalka Andrikovics
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anikó Szilvási
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. András Bors
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. András Kozma
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Emma Ádám
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gabriella Halm
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Éva Karászi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Attila Tordai
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Tamás Masszi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zoltán Mátrai.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mátrai, Z., Andrikovics, H., Szilvási, A. et al. Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia. Pathol. Oncol. Res. 23, 165–171 (2017). https://doi.org/10.1007/s12253-016-0132-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-016-0132-z

Key Words

Search

Navigation